Federal Supply Schedule 36F79718D0364
- Tris Pharma Inc. (UEI: NVJMJ89DAG58) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on September 1, 2023, with a ceiling value of $28,000,000 and an ultimate completion date of August 31, 2028. This indefinite delivery vehicle was awarded without set-asides by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract covers the supply of drugs, pharmaceuticals,...
- This Federal Supply Schedule award was granted to AmerisourceHealth Services LLC, a child entity operating under the Amerisource Health Packaging division, to supply pharmaceuticals, drugs, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract was awarded on September 15, 2023, under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB), with a ceiling value...
- This Federal Supply Schedule contract awards Pharmaessentia USA Corp a multiple-award agreement for the procurement of drugs, pharmaceuticals, and hematology-related products under General Services Administration schedule 61-IB (Pharmaceuticals and Drugs). The contract, effective June 1, 2022, with an ultimate completion date of May 31, 2027, carries a ceiling value of $6,000,000. The award was issued without set-aside restrictions, meaning it was competed among all eligible vendors. Funding...
- Leading Pharma LLC was awarded a multiple-award Federal Supply Schedule contract under GSA Schedule 61-IB (Pharmaceuticals and Drugs) effective September 29, 2024, with an ultimate completion date of September 28, 2029. This civilian contract, funded by Veterans Integrated Service Network 12, carries a ceiling value of $225,000 and was awarded without a set-aside restriction. The contract establishes an indefinite delivery vehicle under which the Department of Veterans Affairs may issue task...
- STI Pharma LLC was awarded a multiple-award Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB) to supply pharmaceutical, drug, and hematology-related products to the Veterans Integrated Service Network 12, a civilian healthcare agency within the Department of Veterans Affairs. The contract, awarded on August 15, 2017, carries a ceiling value of $225,000 and is scheduled for completion by May 14, 2026. As a Federal Supply...
- Patriot Pharmaceuticals LLC has been awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule to provide drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The multiple-award contract, effective January 1, 2023, establishes a ceiling value of $23,177,724 and runs through December 31, 2027. The contract was awarded without a set-aside...
- This Federal Supply Schedule contract was awarded on October 1, 2018, to H2-Pharma LLC (UEI: GDQNVADFEPY8) under the Pharmaceuticals and Drugs schedule (FSS-61-IB) with a ceiling value of $225,000 and a completion date of October 1, 2026. The contract is a multiple-award vehicle without set-asides, funded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract covers the supply of drugs, pharmaceuticals, and hematology-related...
- This Federal Supply Schedule contract, awarded to R-Pharm US LLC (UEI: DCS8XNM7NMW7) on September 1, 2016, establishes a multiple-award indefinite delivery vehicle for the supply of pharmaceuticals, drugs, and hematology-related products under General Services Administration Schedule 61-IB. The contract, funded by the Department of Veterans Affairs through Veterans Integrated Service Network 12, carries a ceiling value of $444,187.20 and runs through August 31, 2026. As a civilian agency...
- This Federal Supply Schedule contract awards Provepharm Inc. (UEI: RQC5M6BKFYK8) a multiple award agreement to provide drugs, pharmaceuticals, and hematology-related products under General Services Administration Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs). The contract was awarded on March 15, 2023, with a ceiling value of $225,000 and an ultimate completion date of March 14, 2028, representing a five-year period of performance. The Veterans Integrated Service Network 12, a...
- ITF Therapeutics LLC was awarded a Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs. The contract, effective May 15, 2025, with a ceiling value of $225,000, authorizes the procurement of drugs, pharmaceuticals, and hematology-related products to support the Veterans Health Administration's medical supply needs. This...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79718D0364Federal Supply Schedule
- Blanket Purchase Agreements
Trupharma LLC was awarded a multiple-award Federal Supply Schedule contract under General Services Administration (GSA) schedule 61-IB (Pharmaceuticals and Drugs) to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract was executed on February 15, 2018, with an ultimate completion date of January 31, 2026, and carries a ceiling value of $2,000,000.00. As a non-set-aside Federal Supply Schedule contract, this award permits the Veterans Integrated Service Network to place orders directly from Trupharma's established price list at negotiated rates throughout the contract period. The contract encompasses the supply of pharmaceutical products, drugs, and hematology-related materials that support the medical needs of the Veterans Health Administration network. Under this indefinite delivery vehicle, the Department of Veterans Affairs may issue task orders or purchase orders at any time during the contract term, up to the established ceiling value, to fulfill ongoing pharmaceutical procurement requirements for VISN 12 facilities. The 2026 Public Law pricing update referenced in the contract description indicates that pricing adjustments were implemented to ensure compliance with applicable statutory requirements during the contract's extended performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00063 | Supplemental Agreement for work within scope | $0 | 12/1/25 | |
| P00062 | Supplemental Agreement for work within scope | $0 | 10/17/25 | |
| P00061 | Supplemental Agreement for work within scope | $0 | 7/17/25 | |
| P00060 | Supplemental Agreement for work within scope | $0 | 6/9/25 | |
| P00059 | Supplemental Agreement for work within scope | $0 | 4/29/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Roxane Laboratories, Inc. 900 Ridgebury Road Ridgefield, CT 06877 | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 8/12/16, 2:39 PM |